Novo Nordisk A/S’s (NVO) “Market Perform” Rating Reiterated at BMO Capital Markets
BMO Capital Markets reissued their market perform rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a report published on Thursday morning, MarketBeat reports. They currently have a $64.00 price objective on the stock, down from their prior price objective of $105.00. NVO has been the topic of a number of other […]
BMO Capital Markets reissued their market perform rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a report published on Thursday morning, MarketBeat reports. They currently have a $64.00 price objective on the stock, down from their prior price objective of $105.00. NVO has been the topic of a number of other […]